testimonial title

 “I am honored to be part of the successes and challenges that ensure we continuously grow”

Andrea Dawson

Senior Director, Commercial Operations & Project Management

Andrea Dawson’s fate was to become an engineer.  Growing up she loved fixing things with her family around their property in rural Prince Edward Island (PEI).  She later graduated with a BEng, Chemical Engineering from Dalhousie University (then TUNS) and was BIOVECTRA’s first engineering student. Andrea went on to carve out a dynamic career path working both in Alberta and Ontario, gaining experience in the manufacturing, energy, and clean technology sectors.  Then an opportunity came to move her young family to PEI.  Her career came full circle when she accepted the role of Director, Manufacturing with BIOVECTRA when she returned in 2010.  Andrea came with considerable engineering and leadership acumen to contribute back to the company where she first cut her teeth as student.  In the past twelve years Andrea has held several key leadership roles in manufacturing and engineering.  She is now the Senior Director leading BIOVECTRA’s project management team, working across departments to ensure clients’ project needs are met. The one-time mentee has become the mentor, as Andrea enjoys encouraging new talent to achieve heights in their BIOVECTRA careers.  

Oliver Technow - Chief Executive Officer

  • Industry Master Degree from Frankfurt Chamber of Commerce, Frankfurt Germany.
  • More than 20 years of global pharmaceutical industry experience.
  • Held numerous leadership positions in commercial development, marketing and brand management, and lifecycle management and has extensive product launch and market access expertise in Europe and North America.
  • In 1997, joined Eisai GmbH in Frankfurt, Germany and in 2002, was appointed Director, CNS Business Unit; in 2006, was appointed Vice President, Head of Global Marketing for Eisai Inc. in Woodcliff Lake, NJ;  in 2011, was appointed Vice President, Established Products Business Unit; in 2013, was appointed President & General Manager for Eisai Limited in Mississauga, ON.
  • Appointed President of BIOVECTRA Inc., December 10, 2015.
  • Board Director for BIOTECanada
  • Member of the Steering Council of Innovative Medicines Canada (IMC)
  • In 2017, appointed to the Government of Canada’s Health/Bio-sciences Strategic Economic Table
  • In November 2019, promoted to Chief Executive Officer at BIOVECTRA
  • In June 2020, named new Chair of PEI BioAlliance Board of Directors